跳至主要内容
临床试验/CTRI/2021/08/035968
CTRI/2021/08/035968尚未招募2 期

To Compare the Efficacy of Nasyakarma and Snehapana in the Managment of Ardhavbhedaka with special refrence to Migraine. - YES

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between 18-60 years of age..
  • 2.Patients with clinical signs and symptoms of Ardhavbhedaka.
  • (Ardhshirovedna, bhrushankha vedna, Shashtravatvedna, Shirahshoola,
  • manya vedna,karna akshi lalat vedna) Migraine.
  • 3.Patients of either gender.
  • 4.Patients who uses analgesic and other medication.
  • 5.Patients fit for Nasyakarma and Snehapana.
  • 6.Patients willing to participate in trial and follow up with a signed
  • informed consent

排除标准

  • 1.Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem, Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc.
  • 2.Patients of sinusitis, hemiplegic migraine, basilar migraine, retinal migraine, status migraines.
  • 3.Headache due to obtains any organic lesion.
  • 4.Headache due to injuries.
  • 5.Headache due to any chronic systemic disease.
  • 6.Pregnant womenâ??s or lactating women.

研究者

相似试验